“…This technology has similarly been used in hyperglycemia in type 1 diabetic subjects using insulin pump therapy (65,66), type 1 diabetic subjects using insulin injections (67), pregnant women with (55)(56)(57)(58)(59)68) and without (68,69) diabetes, gastroparesis patients (70), and cystic fibrosis patients (71). Continuous glucose monitoring has also been used as a therapeutic tool to decrease the incidence and magnitude of hypoglycemia in three studies (46,72,73).…”